September 29th, 2020 was a memorable day as Cristina Lucía Dávila Fajardo obtained her (second!) PhD degree from Leiden University in the Netherlands. Since 2010, she collaborates with Prof. Henk-Jan Guchelaar and Dr. Jesse Swen from the Leiden University Medical Center in pharmacogenetics research.
On September 2nd, 2020 Cathelijne van der Wouden obtained her PhD degree from Leiden University in the Netherlands. She started her PhD in 2016 in the research group of Prof. Henk-Jan Guchelaar and Dr. Jesse Swen from the Leiden University Medical Center.
As per October 1st 2018, the PREPARE study sites have crossed-over to the opposite arm! Since then, more than 2,500 patients have been enrolled in the PREPARE study. Continue reading
The 3rd U-PGx Personalized Medicine Public Day was successfully co-organized in Patras, Greece by the Golden Helix Foundation together with the University of Patras, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy (Patras, Greece). Continue reading
A practice paper “Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts” analysing educational needs to develop pharmacogemomics from science to patient care and about our U-PGx perspective was recently published in Clinical Pharmacology & Therapeutics. Continue reading
One of the most important prerequisites of the successful implementation of pharmacogenomics into the clinic is the increase of the general public’s awareness over the benefits of pharmacogenomics in rationalizing drug use. Continue reading
WP8 of the U-PGx project provides an Ethical, Legal and Societal Implications (ELSI) expertise and education on ethical and legal aspects regarding Pharmacogenomics (PGx). Continue reading
In the PREPARE study participants are genotyped pre-emptively, but what to do for all other patients? Can you initiate therapy without pre-emptive testing or is genotyping necessary for specific drugs? Continue reading
The 6th U-PGx Personalized Medicine Day will be organized in Athens, Greece on December 13th, 2019. Continue reading
As per October 1st 2018, the PREPARE study sites have crossed-over to the opposite arm! Since then, more than 1,000 patients have been enrolled in the PREPARE study. When adding this number up to the number of patients enrolled before cross-over we come to a total of 4,772 patients. Continue reading